Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Hess

Showing results (51-60 of 217) with videos related to

Pageof 22
Sort By:
Cancer|August 30, 2008
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancerHenry Q Xiong, Gauri R Varadhachary, Joan C Blais, et al.
The Oncologist|March 25, 2015
Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysisQi Shen, Aysegul A Sahin, Kenneth R Hess, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2018
Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic reviewVaibhav Gupta, Natalie Coburn, Biniam Kidane, et al.
The Breast Journal|February 29, 2020
The role of magnetic resonance imaging in patients with palpable breast abnormalities and negative mammographic and sonographic findingsCeren Yalniz, Danea Campbell, Carisa Le-Petross, et al.
Chemistryselect|June 25, 2021
Paired Spectroscopic and Crystallographic Studies of ProteasesMeiqi Luo, Christopher N Eaton, Kenneth R Hess, et al.
Plos One|July 3, 2015
Reproducibility of Variant Calls in Replicate Next Generation Sequencing ExperimentsYuan Qi, Xiuping Liu, Chang-Gong Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancerXiaoqun Dong, Li Jiao, Yanan Li, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2013
A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastasesApostolia M Tsimberidou, Yang Ye, Jennifer Wheler, et al.
Cancer|June 29, 2004
Overexpression of synuclein-gamma in pancreatic adenocarcinomaZhongkui Li, Guido M Sclabas, Bailu Peng, et al.
Molecular Cancer|November 12, 2009
Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitroJheri J Dupart, Jonathan C Trent, Ho-Young Lee, et al.
Pageof 22

Showing results (51-60 of 217) with videos related to

Sort By:
Pageof 22
Cancer|August 30, 2008
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancerHenry Q Xiong, Gauri R Varadhachary, Joan C Blais, et al.
The Oncologist|March 25, 2015
Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysisQi Shen, Aysegul A Sahin, Kenneth R Hess, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2018
Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic reviewVaibhav Gupta, Natalie Coburn, Biniam Kidane, et al.
The Breast Journal|February 29, 2020
The role of magnetic resonance imaging in patients with palpable breast abnormalities and negative mammographic and sonographic findingsCeren Yalniz, Danea Campbell, Carisa Le-Petross, et al.
Chemistryselect|June 25, 2021
Paired Spectroscopic and Crystallographic Studies of ProteasesMeiqi Luo, Christopher N Eaton, Kenneth R Hess, et al.
Plos One|July 3, 2015
Reproducibility of Variant Calls in Replicate Next Generation Sequencing ExperimentsYuan Qi, Xiuping Liu, Chang-Gong Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancerXiaoqun Dong, Li Jiao, Yanan Li, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2013
A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastasesApostolia M Tsimberidou, Yang Ye, Jennifer Wheler, et al.
Cancer|June 29, 2004
Overexpression of synuclein-gamma in pancreatic adenocarcinomaZhongkui Li, Guido M Sclabas, Bailu Peng, et al.
Molecular Cancer|November 12, 2009
Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitroJheri J Dupart, Jonathan C Trent, Ho-Young Lee, et al.
Pageof 22